Medical College of Wisconsin
CTSIResearch InformaticsREDCap

CURRICULUM VITAE

Thomas B. Connor MD
Professor
Department of Ophthalmology

OFFICE ADDRESS:
925 North 87th Street
Milwaukee, WI 53226

EDUCATION:
09/01/1973 - 06/01/1977 High School Diploma, Gilman School, Baltimore, MD
09/01/1977 - 06/01/1981 BS, Haverford College, Haverford, PA
09/01/1983 - 06/01/1988 MD, Johns Hopkins School of Medicine, Baltimore, MD

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
07/01/1988 - 06/30/1989 Intern, Internal Medicine, Beth Israel Hospital/Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215
07/01/1989 - 06/20/1992 Resident, Ophthalmology, Wilmer Eye Institute/Johns Hopkins Hospital, 1800 Orleans St, Baltimore, MD 21287
07/01/1992 - 06/30/1993 Fellow, Ophthalmology, Vitreoretinal Surgery and Diseases, Medical College of Wisconsin Eye Institute, 925 N 87th Street, MCW Eye Institute, Milwaukee, WI 53226

FACULTY APPOINTMENTS:
07/01/1993 - 06/30/1994 Assistant Chief of Service, Instructor, Ophthalmology, Director Ocular Trauma Service, Wilmer Eye Institute Johns Hopkins Hospital, 1800 Orleans St, Baltimore, MD 21287
09/01/1994 - 06/30/1999 Assistant Professor, Ophthalmology, Medical College of Wisconsin, 925 N 87th Street, MCW Eye Institute, Milwaukee, WI 53226
07/01/1999 - 06/30/2014 Associate Professor, Ophthalmology, Medical College of Wisconsin, 925 N 87th Street, MCW Eye Institute, Milwaukee, WI 53226
07/01/2014 - Present Professor, Ophthalmology, Medical College of Wisconsin, 925 N 87th Street, MCW Eye Institute, WI 53226

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
07/1995 Course Director - Advanced Vitreoretinal Surgery Symposium, Ophthalmology, MCW Eye Institute, American Club, Kohler, WI
1995 - 2026 M1, M3 Ophthalmology Course Lecturer, Ophthalmology, MCW Eye Institute, 925 N 87th Street, MCW Eye Institute, Milwaukee, WI 53226
10/1996 - 06/2000 Program Co-Director, Ophthalmology, Living with Low Vision Program 8 public forums delivered, Medical College of Wisconsin, 925 N 87th Street, MCW Eye Institute, Milwaukee, WI 53226
1997 - 2003 Course Director - Mid-Winter Retina Symposium, Ophthalmology, MCW Eye Institute, 925 N 87th Street, MCW Eye Institute, Milwaukee, WI 53226
1997 - 2007 Co-Chair, Residency Training Committee, Ophthalmology, MCW Eye Institute, 925 N 87th Street, MCW Eye Institute, Milwaukee, WI 53226
1997 - 2007 Coordinator - Ophthalmology Grand Rounds, Ophthalmology, MCW Eye Institute, 925 N 87th Street, MCW Eye Institute, Milwaukee, WI 53226
1997 - 2007 Faculty Liaison - JCAHO, Ophthalmology, Eye Institute - MCW & Froedtert Hospital, 925 N 87th Street, MCW Eye Institute, Milwaukee, WI 53226
06/2000 Co-Director Midwwest Ocular Angiography Conference, Ophthalmology, MCW Eye Institute, Girdwood, AK
2002 - 2026 Director- Retina Fellowship, Ophthalmology, MCW Eye Institute, 925 N 87th Street, MCW Eye Institute, Milwaukee, WI 53226

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
1994 - 1999 Director, Ophthalmology, Vitreoretinal Services, Milwaukee VAMC, 500 W National Ave, Milwaukee, WI 53295
1999 - 2007 Chairman - Surgical Services Committee, Ophthalmology, Froedtert Memorial Lutheran Hospital - Eye Institute, 925 N 87th Street, MCW Eye Institute, WI 53226
1999 - 2008 Ophthalmology Department Representative, Quality Improvement Committee, Froedtert Memorial Lutheran Hospital, 900 N 92nd St, MCW Eye Institute, Milwaukee, WI 53226
2012 - Present Committee Member and Ophthalmology Department Champion, FMLH Disclosure Committee, Froedtert Memorial Lutheran Hospital, 900 N 92nd St, Milwaukee, WI 53226
2020 - Present Grateful Patients - Ophthalmology Department Champion, Advancement, Froedtert Memorial Lutheran Hospital, 900 N 92nd St, Milwaukee, WI 53226
2020 - Present Committee Member, Pharmacy & Therapeutics Innovative Therapies Committee, Froedtert Memorial Lutheran Hospital, 900 N 92nd St, Milwaukee, WI 53226

HOSPITAL STAFF PRIVILEGES:
09/01/1994 - Present Full-time Staff, Froedtert Memorial Lutheran Hospital, 925 N 87th Street, MCW Eye Institute, Milwaukee, WI 53226
09/01/1994 - Present Full-time staff, Children's Hospital of Wisconsin, 8915 W Connell Ct, Milwaukee, WI 53226
09/01/1994 - Present Courtesy Staff, Ophthalmology, Milwaukee VAMC, 5000 W National Ave, Milwaukee, WI 53295
01/01/2001 - Present Full Time Staff, Ophthalmology, Medical College of Wisconsin Clinics, 9200 W Wisconsin Ave, MCW, Milwaukee, WI 53226

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
05/1995
None
   
Licensure
Number Issue DateExpiration
Physician and Surgeon
D45847
07/1993
None
Physician and Surgeon
35377
09/01/1994
2026
    

AWARDS AND HONORS:
1986 - 1987 Deans Stipend Award for Research Fellowship, Johns Hopkins School of Medicine
1988 Upjohn Prize for excellence in clinical proficiency and achievement, Johns Hopkins School of Medicine
1988 Alpha Omega Alpha, Johns Hopkins School of Medicine
1993 Teacher of the Year, Medical College of Wisconsin Eye Institute
1994 Wilmer Nursing Association Appreciation Award, Wilmer Eye Institute Johns Hopkins Hospital
1995 Teacher of the Year, Medical College of Wisconsin Eye Institute
1996 - 2026 Best Doctors in America
1998 Honor Award, American Academy of Ophthalmology
1999 IRIS Award for Innovation, Wiscraft
2009 Teacher of the Year, Medical College of Wisconsin Eye Institute
2023 Notable Health Care Leaders, BizTimes/ Milwaukee Business News

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
1986 - Present Association for Research in Vision and Ophthalmology (member)
1991 - Present American Academy of Ophthalmology (member)
1995 - Present American Medical Association (member)
1995 - Present Milwaukee Ophthalmological Society (member)
1997 - Present Vitreous Society/American Society of Retina Specialists (member)
1998 - Present Wisconsin Academy of Ophthalmology (member)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorial Board
1996 - Present Ocular Surgery News
Journal Review
1993 - Present Retina
1993 - Present Journal of Pediatric Ophthalmology and Strabismus
1993 - Present Archives of Ophthalmology/JAMA Ophthalmology
1993 - Present Investigative Ophthalmology and Visual Science
1993 - Present Experimental Eye Research
1993 - Present American Journal of Ophthalmology
1997 - Present Ophthalmology

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2010 - 2011 Treasurer, Milwaukee Ophthalmological Society
2010 - 2014 Officer, Milwaukee Ophthalmological Society
2011 - 2012 Secretary, Milwaukee Ophthalmological Society
2012 - 2013 Committee Member and Guest Speaker, Education Advisory Committee, Prevent Blindness Wisconsin
2012 - 2013 Vice-President, Milwaukee Ophthalmological Society
2013 - 2014 President, Milwaukee Ophthalmological Society
2013 - 2014 Co-Chair, Dining in the Dark Fundraising Event, Vision Forward Association

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2007 - 2010 Executive Committee, "Eye on AMD" Public Education and Awareness, American Society of Retina Specialists

MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Medical Students
2012 - Present MCW Eye Institute Summer Student Program, Directed Wet Lab, Medical College of Wisconsin, Eye Anatomy and Dissection
 
Postdoctoral Researchers
2015 - 2016 Lynn Sunn Md PhD, Project Advisor, Medical College of Wisconsin
 
Clinical/Research Fellows
1994 - 1995 Jerry Blair MD PhD, Clinical Vitreoretinal Fellow, Medical College of Wisconsin
1994 - 1996 Judy Kim MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
1994 - 1995 Sharoth Khani MD PhD, Clinical Vitreoretinal Fellow, Medical College of Wisconsin
1995 - 1997 John Pollack MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
1995 - 1996 Eric Postel MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
1996 - 1998 Robert Mittra MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
1997 - 1999 Sundeep Dev MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
1998 - 2000 William Wirostko MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
1999 - 2001 Stephen Perkins MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2000 - 2002 Dariusz Tarasewicz MD PhD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2001 - 2003 Steven H. Kim MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2002 - 2004 Kekul Shah MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2003 - 2005 S. Jin Moon MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2004 - 2006 Richard Hamilton MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2005 - 2007 Craig Lemley MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2006 - 2008 Sandeep Shah MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2007 - 2009 Dara Koozekanani MD PhD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2008 - 2010 Douglas Covert MD MPH, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2009 - 2011 Rashmi Kapur MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2010 - 2012 Brian Larsen MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2011 - 2013 Ravi Singh MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2012 - 2014 David Reichstein MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2013 - 2015 Mohamed Gendy MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2014 - 2016 James Kim MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2015 - 2017 Alessa S. Crossan MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2016 - 2018 Clinton C. Warren MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2017 - 2019 Eileen Hwang MD PhD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2018 - 2020 Raafay Sophie MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2019 - 2021 Jonathan Greenburg MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2020 - 2022 Salman Sarwar MD, Clinical Vitreoretinal Fellow, Medical College of Wisconsin
2021 - 2023 Monica P. Gonzalez MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2022 - 2024 Johnny Lippincott MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2023 - 2025 Shivam Amin MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2024 - 2026 Anthony Jones DO, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
2025 - 2027 Amin Karadaghy MD, Clinical Vitreoretinal Fellowship, Medical College of Wisconsin
 
Residents
1996 - 1999 Kumar Rao MD, Research Advisor, Medical College of Wisconsin
1998 - 2001 Darrin Levin MD, Research advisor, Medical College of Wisconsin
1999 - 2002 Matthew Carnahan MD, Research Advisor, Medical College of Wisconsin
2000 - 2003 Mohan Iyer MD, Research Advisor, Medical College of Wisconsin
2003 - 2006 Ronald Mancini MD, Research Advisor, Medical College of Wisconsin
2004 - 2007 Anand Montravadi MD, Research Advisor, Medical College of Wisconsin
2005 - 2008 Douglas Covert ND MPH, Research Advisor, Medical College of Wisconsin
2006 - 2009 Radi Kumar MD, Faculty Advisor, Medical College of Wisconsin
2008 - 2011 Jonothan Schell MD, Medical College of Wisconsin
2011 - 2014 John McAllister MD, Faculty Advisor, Medical College of Wisconsin
2015 - 2016 Clinton Warren MD, Research Advisor, Medical College of Wisconsin
2022 - 2024 Anthony Jones DO, Educational Advisor, Medical College of Wisconsin
2023 - 2024 Roxana Godiwalla MD, Education Advisor, Medical College of Wisconsin
 

COMMUNITY SERVICE ACTIVITIES:
1994 - 2014 Bel Canto Chorus Member
1994 - 1999 West Suburban YMCA Development Board
1995 - 2000 Bel Canto Chorus Board Member
1995 - 2000 Volunteer - Habitat for Humanity
2005 - 2010 Boy Scouts of America - Leader: Cub Scout Pack 183
2005 - 2010 Boy Scouts of America - Leader: Cub Scout Pack 183
2007 - 2016 Youth Sports Coach Basketball - Elmbrook Church/ Boys & Girls Brookfield Pak & Rec- Boys Brookfield Academy - Boys Soccer - Brookfield Park & Rec - Girls Football - Brookfield Academy Junior Knights Lacrosse - Brookfield Lacrosse Association Baseball - Town of Brookfield - Park & Rec Brookfield Park & Rec Elm Brook Little League
2010 - 2020 Assistant Scoutmaster Troop 183
2013 Honorary Chair and Featured Speaker - Dining in the Dark, Vision Forward Association
2015 - 2019 Scientific Co-Chair, Milwaukee Vison Walk - Foundation for Fighting Blindness
2022 - 2026 Community United Methodist Church - Elm Grove Member - Servant Leadership Team
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Glaser BM, Connor TB. Protamine inhibits plasminogen activator derived from vascular endothelial cells and tumor cells Journal of Cell Biology. 1982;95(2 II).
2. Glaser BM, Kalebic T, Garbisa S, Connor TB Jr, Liotta LA. Degradation of basement membrane components by vascular endothelial cells: role in neovascularization. Ciba Found Symp. 1983;100:150-62.
3. Connor T, Braunstein B. Hyperpigmentation following the use of bleaching creams. Localized exogenous ochronosis. Arch Dermatol. 1987 Jan;123(1):105-6, 108.
4. Connor TB Jr, Roberts AB, Sporn MB, Danielpour D, Dart LL, Michels RG, de Bustros S, Enger C, Kato H, Lansing M. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest. 1989 May;83(5):1661-6. PMCID: PMC303874
5. Smiddy WE, Glaser BM, Green WR, Connor TB Jr, Roberts AB, Lucas R, Sporn MB. Transforming growth factor beta. A biologic chorioretinal glue. Arch Ophthalmol. 1989 Apr;107(4):577-80.
6. Maguire AM, Zarbin MA, Connor TB, Justin J. Ocular penetration of thiabendazole. Arch Ophthalmol. 1990 Dec;108(12):1675.
7. Connor TB, Pulido JS. Management of aphakic and pseudophakic cystoid macular edema Current Opinion in Ophthalmology. 1993;4(3):90-101.
8. Raja SC, Fekrat S, Connor TB Jr. Bilateral macular vitelliform lesions in a thrombocytopenic patient. Arch Ophthalmol. 1995 Apr;113(4):411-3.
9. Connor TB, Guyton DL, Repka MX, Jain R. The adjustable globe: a technique for adjustable strabismus surgery. J Pediatr Ophthalmol Strabismus. 1996;33(3):156-63.
10. Wirostko WJ, Han OP, Mieler WF, Pulido JS, Connor TB, Hartz AJ, Guse CE. Suprachoroidal hemorrhage: A classification of severity and its association with visual and anatomic outcome Investigative Ophthalmology and Visual Science. 1997;38(4):S670.
11. Mittra RA, Connor TB, Han DP, Koenig SB, Mieler WF, Pulido JS. Removal of dislocated intraocular lenses using pars plana vitrectomy with placement of an open-loop, flexible anterior chamber lens. Ophthalmology. 1998 Jun;105(6):1011-4.
12. Han DP, Mohsin NC, Guse CE, Hartz A, Tarkanian CN. Comparison of pneumatic retinopexy and scleral buckling in the management of primary rhegmatogenous retinal detachment. Southern Wisconsin Pneumatic Retinopexy Study Group. Am J Ophthalmol. 1998 Nov;126(5):658-68.
13. Tang WM, Pulido JS, Connor TB Jr, Sternberg P Jr, Lewandowski MF. Echographic characteristics of retinal arterial macroaneurysm. Retina. 1998;18(6):559-63.
14. Mittra RA, Pollack JS, Dev S, Han DP, Mieler WF, Connor TB. The use of topical aqueous suppressants in the prevention of postoperative intraocular pressure elevation following pars plana vitrectomy with long-acting gas tamponade. Trans Am Ophthalmol Soc. 1998;96:143-51; discussion 151-4. PMCID: PMC1298393
15. Banker AS, Freeman WR, Azen SP, Lai MY. A multicentered clinical study of serum as adjuvant therapy for surgical treatment of macular holes. Vitrectomy for Macular Hole Study Group. Arch Ophthalmol. 1999 Nov;117(11):1499-502.
16. Mittra RA, Pollack JS, Dev S, Han DP, Mieler WF, Pulido JS, Connor TB. The use of topical aqueous suppressants in the prevention of postoperative intraocular pressure elevation after pars plana vitrectomy with long-acting gas tamponade. Ophthalmology. 2000 Mar;107(3):588-92.
17. Mastey RR, Otto M, Connor TB Jr, Carroll J. Incidental Finding of Stargardt Disease in a Healthy Control. JAMA Ophthalmol. 2026 Jan 01;144(1):112-114. PMCID: PMC13214147
18. Hogg HDJ, Brittain K, Talks J, Keane PA, Technology Enhanced Macular Services Study Reference Group, Maniatopoulos G. Intervention design for artificial intelligence-enabled macular service implementation: a primary qualitative study. Implement Sci Commun. 2024 Nov 26;5(1):131. PMCID: PMC11600873
19. Gaffney M, Connor TB, Cooper RF. Intensity-based optoretinography reveals sub-clinical deficits in cone function in retinitis pigmentosa. Front Ophthalmol (Lausanne). 2024;4:1373549. PMCID: PMC11182324
20. Yu CT, Kandoi S, Periasamy R, Reddy LVK, Follett HM, Summerfelt P, Martinez C, Guillaume C, Bowie O, Connor TB, Lipinski DM, Allen KP, Merriman DK, Carroll J, Lamba DA. Human iPSC-derived photoreceptor transplantation in the cone dominant 13-lined ground squirrel. Stem Cell Reports. 2024 Mar 12;19(3):331-342. PMCID: PMC10937153
21. Chew EY, Clemons TE, Agrón E, Domalpally A, Keenan TDL, Vitale S, Weber C, Smith DC, Christen W, AREDS2 Research Group. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28. JAMA Ophthalmol. 2022 Jul 01;140(7):692-698. PMCID: PMC9164119
22. Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA, SCORE2 Study Investigator Group. Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18. JAMA Ophthalmol. 2022 May 01;140(5):458-464. PMCID: PMC8949717
23. Langlo CS, Trotter A, Reddi HV, Schilter KF, Tyler RC, Udani R, Neitz M, Carroll J, Connor TB. Long-term retinal imaging of a case of suspected congenital rubella infection American Journal of Ophthalmology Case Reports. March 2022;25.
24. Maguire MG, Liu D, Bressler SB, Friedman SM, Melia M, Stockdale CR, Glassman AR, Sun JK, DRCR Retina Network. Lapses in Care Among Patients Assigned to Ranibizumab for Proliferative Diabetic Retinopathy: A Post Hoc Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 2021 Dec 01;139(12):1266-1273. PMCID: PMC8532036
25. Low SWY, Connor TB, Kassem IS, Costakos DM, Chaurasia SS. Small leucine-rich proteoglycans (Slrps) in the retina International Journal of Molecular Sciences. 2 July 2021;22(14).
26. Khurana RN, Oden NL, VanVeldhuisen PC, Scott IU, Blodi BA, Ip MS, SCORE2 Investigator Group. Association between early and late response in eyes with central or hemiretinal vein occlusion treated with anti-VEGF agents : SCORE2 report 12: secondary analysis of the SCORE2 clinical trial. Graefes Arch Clin Exp Ophthalmol. 2021 Jul;259(7):1839-1851. PMCID: PMC8260624
27. Gopalakrishnan S, Mehrvar S, Maleki S, Schmitt H, Summerfelt P, Dubis AM, Abroe B, Connor TB Jr, Carroll J, Huddleston W, Ranji M, Eells JT. Photobiomodulation preserves mitochondrial redox state and is retinoprotective in a rodent model of retinitis pigmentosa. Sci Rep. 2020 Nov 23;10(1):20382. PMCID: PMC7684292
28. Avery RL, Connor TB Jr, Farazdaghi M. Systemic amiloride inhibits experimentally induced neovascularization. Arch Ophthalmol. 1990 Oct;108(10):1474-6.
29. Connor TB Jr, Wolf MD, Arrindell EL, Mieler WF. Surgical removal of an extrafoveal fibrotic choroidal neovascular membrane with foveal serous detachment in age-related macular degeneration. Retina. 1994;14(2):125-9.
30. Law SK, Kalenak JW, Connor TB Jr, Pulido JS, Han DP, Mieler WF. Retinal complications after aqueous shunt surgical procedures for glaucoma. Arch Ophthalmol. 1996 Dec;114(12):1473-80.
31. Mittra RA, Connor TB, Han OP, Mieler WF, Pulido JS. Management of dislocated posterior chamber intraocular lenses using pars plana vitrectomy combined with insertion of an anterior chamber lens Investigative Ophthalmology and Visual Science. 1997;38(4):S667.
32. Mittra RA, Huynh LT, Ruttum MS, Mieler WF, Connor TB, Han DP, Pulido JS, Dev S. Visual outcomes following lensectomy and vitrectomy for combined anterior and posterior persistent hyperplastic primary vitreous. Arch Ophthalmol. 1998 Sep;116(9):1190-4.
33. Leahey AB, Connor TB, Gottsch JD. Chemosis as a presenting sign of systemic lupus erythematosus. Arch Ophthalmol. 1992 May;110(5):609-10.
34. Law SK, Kalenak JK, Connor TB, Pulido JS, Han DP, Mieler WF. Retinal complications following glaucoma aqueous-shunt surgery Investigative Ophthalmology and Visual Science. 15 February 1996;37(3):S257.
35. Wirostko WJ, Han DP, Mieler WF, Pulido JS, Connor TB Jr, Kuhn E. Suprachoroidal hemorrhage: outcome of surgical management according to hemorrhage severity. Ophthalmology. 1998 Dec;105(12):2271-5.
36. Dev S, Pulido JS, Tessler HH, Mittra RA, Han DP, Mieler WF, Connor TB Jr. Progression of diabetic retinopathy after endophthalmitis. Ophthalmology. 1999 Apr;106(4):774-81.
37. Ruttum M, Connor TB Jr, Traboulsi EI. A 14-year old boy with presumed autosomal dominant macular dystrophy causing moderate visual impairment with no discernible progression over several years. J Pediatr Ophthalmol Strabismus. 1999;36(5):287-91.
38. Wirostko WJ, Connor TB Jr, Wagner PF. Recurrent poststreptococcal uveitis. Arch Ophthalmol. 1999 Dec;117(12):1649-50.
39. Wirostko WJ, Mieler WF, Levin DS, Law SK, Kalenak JW, Trible JR, Connor TB Jr, Pulido JS, Han DP. Hypotony and retinal complications after aqueous humor shunt implantation: the 1999 Dohlman Lecture. Int Ophthalmol Clin. 2000;40(1):1-12.
40. Levin DS, Han DP, Dev S, Wirostko WJ, Mieler WF, Connor TB, George V, Eastwood D. Subtenon's depot corticosteroid injections in patients with a history of corticosteroid-induced intraocular pressure elevation. Am J Ophthalmol. 2002 Feb;133(2):196-202.
41. Kim JE, Landon RE, Connor TB Jr, Kivlin JD. Endogenous ocular nocardiosis. J AAPOS. 2004 Apr;8(2):194-5.
42. Iyer MN, Han DP, Yun HJ, Eastwood D, Kim JE, Connor TB, Wirostko WJ, Dev S. Subconjunctival antibiotics for acute postcataract extraction endophthalmitis--is it necessary? Am J Ophthalmol. 2004 Jun;137(6):1120-1.
43. Kim JE, Perkins SL, Schwiesow T, Connor TB Jr, Han DP. Transpupillary thermotherapy of occult choroidal neovascularization in age-related macular degeneration. Semin Ophthalmol. 2001 Jun;16(2):86-9.
44. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR, VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med. 2004 Dec 30;351(27):2805-16.
45. Kuppermann BD, Thomas EL, de Smet MD, Grillone LR, Vitrase for Vitreous Hemorrhage Study Groups. Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol. 2005 Oct;140(4):573-84.
46. Cunningham ET Jr, Adamis AP, Altaweel M, Aiello LP, Bressler NM, D'Amico DJ, Goldbaum M, Guyer DR, Katz B, Patel M, Schwartz SD, Macugen Diabetic Retinopathy Study Group. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology. 2005 Oct;112(10):1747-57.
47. Kuppermann BD, Thomas EL, de Smet MD, Grillone LR, Vitrase for Vitreous Hemorrhage Study Groups. Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol. 2005 Oct;140(4):585-97.
48. Dev S, Han DP, Mieler WF, Gonzalez-Vivas R, Pulido JS, Mittra RA, Connor TB. The role of intravitreal dexamethasone as an adjunct in the management of postoperative bacterial endophthalmitis Evrs Educational Electronic Journal. 2005;1(5):10-17.
49. Mruthyunjaya P, Wirostko WJ, Chandrashekhar R, Stinnett S, Lai JC, Deramo V, Tang J, Dev S, Postel EA, Connor TB, Fekrat S. Central retinal vein occlusion in patients treated with long-term warfarin sodium (Coumadin) for anticoagulation. Retina. 2006 Mar;26(3):285-91.
50. Kim JE, Shah KB, Han DP, Connor TB Jr. Transpupillary thermotherapy with indocyanine green dye enhancement for the treatment of occult subfoveal choroidal neovascularization in age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2006;37(4):272-7.
51. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S, ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006 Oct 05;355(14):1432-44.
52. Boyer DS, Antoszyk AN, Awh CC, Bhisitkul RB, Shapiro H, Acharya NR, MARINA Study Group. Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology. 2007 Feb;114(2):246-52.
53. Mancuso K, Hendrickson AE, Connor TB Jr, Mauck MC, Kinsella JJ, Hauswirth WW, Neitz J, Neitz M. Recombinant adeno-associated virus targets passenger gene expression to cones in primate retina. J Opt Soc Am A Opt Image Sci Vis. 2007 May;24(5):1411-6.
54. Kaiser PK, Blodi BA, Shapiro H, Acharya NR, MARINA Study Group. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology. 2007 Oct;114(10):1868-75.
55. Chang TS, Bressler NM, Fine JT, Dolan CM, Ward J, Klesert TR, MARINA Study Group. Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 2007 Nov;125(11):1460-9.
56. Covert DJ, Wirostko WJ, Han DP, Lindgren KE, Hammersley JA, Connor TB, Kim JE. Risk factors for scleral buckle removal: a matched, case-control study. Trans Am Ophthalmol Soc. 2008;106:171-7; discussion 177-8. PMCID: PMC2646451
57. Bhavsar AR, Grillone LR, McNamara TR, Gow JA, Hochberg AM, Pearson RK, Vitrase for Vitreous Hemorrhage Study Groups. Predicting response of vitreous hemorrhage after intravitreous injection of highly purified ovine hyaluronidase (Vitrase) in patients with diabetes. Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4219-25.
58. Mauck MC, Mancuso K, Kuchenbecker JA, Connor TB, Hauswirth WW, Neitz J, Neitz M. Longitudinal evaluation of expression of virally delivered transgenes in gerbil cone photoreceptors. Vis Neurosci. 2008;25(3):273-82. PMCID: PMC2643299
59. Covert DJ, Wirostko WJ, Han DP, Lindgren KE, Hammersley JA, Connor TB, Kim JE. Risk factors for scleral buckle removal: a matched, case-control study. Am J Ophthalmol. 2008 Sep;146(3):434-439.
60. Browning DJ, Glassman AR, Aiello LP, Bressler NM, Bressler SB, Danis RP, Davis MD, Ferris FL, Huang SS, Kaiser PK, Kollman C, Sadda S, Scott IU, Qin H, Diabetic Retinopathy Clinical Research Network. Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology. 2008 Aug;115(8):1366-71, 1371.e1. PMCID: PMC2748270
61. Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T, ANCHOR Study Group. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology. 2009 Jan;116(1):57-65.e5.
62. Bressler NM, Chang TS, Fine JT, Dolan CM, Ward J, Anti-VEGF Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization in Age-Related Macular Degeneration (ANCHOR) Research Group. Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trial. Arch Ophthalmol. 2009 Jan;127(1):13-21.
63. Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Jumper JM, Figueroa M, SCORE Study Investigator Group. SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. Ophthalmology. 2009 Mar;116(3):504-12. PMCID: PMC2851408
64. Wirostko WJ, Covert DJ, Han DP, Connor TB Jr, Kim JE, Hammersley J, Lindgren K. Microbiological spectrum of organisms isolated from explanted scleral buckles. Ophthalmic Surg Lasers Imaging. 2009;40(2):201-2.
65. Wroblewski JJ, Wells JA 3rd, Adamis AP, Buggage RR, Cunningham ET Jr, Goldbaum M, Guyer DR, Katz B, Altaweel MM, Pegaptanib in Central Retinal Vein Occlusion Study Group. Pegaptanib sodium for macular edema secondary to central retinal vein occlusion. Arch Ophthalmol. 2009 Apr;127(4):374-80.
66. George B, Wirostko WJ, Connor TB, Choong NW. Complete and durable response of choroid metastasis from non-small cell lung cancer with systemic bevacizumab and chemotherapy. J Thorac Oncol. 2009 May;4(5):661-2.
67. Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA, Antoszyk AN, SCORE Study Investigator Group. SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design. Am J Ophthalmol. 2009 Nov;148(5):725-732.e7. PMCID: PMC2780008
68. Kim JE, Shah SN, Choi DL, Han DP, Connor TB. Transconjunctival 20-gauge pars plana vitrectomy using a single entry cannulated sutureless system. Retina. 2009 Oct;29(9):1294-8.
69. Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Singerman LJ, Tolentino M, Chan CK, Gonzalez VH, SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol. 2009 Sep;127(9):1101-14. PMCID: PMC2872173
70. Mancuso K, Hauswirth WW, Li Q, Connor TB, Kuchenbecker JA, Mauck MC, Neitz J, Neitz M. Gene therapy for red-green colour blindness in adult primates. Nature. 2009 Oct 08;461(7265):784-7. PMCID: PMC2782927
71. Covert DJ, Han DP, Kim JE, Connor TB Jr, Wirostko WJ, Moon SJ, Hamilton R. Physician assessment of changing lesion size of predominantly classic choroidal neovascular membranes in age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2009;40(6):554-60.
72. Koozekanani DD, Connor TB Jr, Wirostko WJ. RetCam II Fluorescein Angiography to Guide Treatment and Diagnosis of Coats Disease. Ophthalmic Surg Lasers Imaging. 2010 Mar 09:1-3.
73. Diabetic Retinopathy Clinical Research Network, Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, Edwards AR, Ferris FL 3rd, Friedman SM, Glassman AR, Miller KM, Scott IU, Stockdale CR, Sun JK. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010 Jun;117(6):1064-1077.e35. PMCID: PMC2937272
74. Friberg TR, Tolentino M, LEVEL Study Group, Weber P, Patel S, Campbell S, Goldbaum M. Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study. Br J Ophthalmol. 2010 Dec;94(12):1611-7. PMCID: PMC2991041
75. Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Hartnett ME, Cohen G, Standard Care versus COrticosteroid for REtinal Vein Occlusion Study Investigator Group. Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10. Ophthalmology. 2011 Feb;118(2):345-52. PMCID: PMC3020981
76. Sultan MB, Zhou D, Loftus J, Dombi T, Ice KS, Macugen 1013 Study Group. A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema. Ophthalmology. 2011 Jun;118(6):1107-18.
77. Gangaputra S, Almukhtar T, Glassman AR, Aiello LP, Bressler N, Bressler SB, Danis RP, Davis MD, Diabetic Retinopathy Clinical Research Network. Comparison of film and digital fundus photographs in eyes of individuals with diabetes mellitus. Invest Ophthalmol Vis Sci. 2011 Aug 03;52(9):6168-73. PMCID: PMC3176025
78. Loftus JV, Sultan MB, Pleil AM, Macugen 1013 Study Group. Changes in vision- and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or sham. Invest Ophthalmol Vis Sci. 2011 Sep 29;52(10):7498-505.
79. Godara P, Wagner-Schuman M, Rha J, Connor TB Jr, Stepien KE, Carroll J. Imaging the photoreceptor mosaic with adaptive optics: beyond counting cones. Adv Exp Med Biol. 2012;723:451-8. PMCID: PMC3325514
80. Carroll J, Dubra A, Gardner JC, Mizrahi-Meissonnier L, Cooper RF, Dubis AM, Nordgren R, Genead M, Connor TB Jr, Stepien KE, Sharon D, Hunt DM, Banin E, Hardcastle AJ, Moore AT, Williams DR, Fishman G, Neitz J, Neitz M, Michaelides M. The effect of cone opsin mutations on retinal structure and the integrity of the photoreceptor mosaic. Invest Ophthalmol Vis Sci. 2012 Dec 05;53(13):8006-15. PMCID: PMC3816954
81. Busbee BG, Ho AC, Brown DM, Heier JS, Suñer IJ, Li Z, Rubio RG, Lai P, HARBOR Study Group. Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration. Ophthalmology. 2013 May;120(5):1046-56.
82. Diabetic Retinopathy Clinical Research Network*. Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy. JAMA Ophthalmol. 2013 Mar;131(3):283-93. PMCID: PMC4217122
83. Danis RP, Domalpally A, Chew EY, Clemons TE, Armstrong J, SanGiovanni JP, Ferris FL 3rd, AREDS2 Study Group. Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2). Invest Ophthalmol Vis Sci. 2013 Jul 08;54(7):4548-54. PMCID: PMC3706107
84. Bressler SB, Qin H, Melia M, Bressler NM, Beck RW, Chan CK, Grover S, Miller DG, Diabetic Retinopathy Clinical Research Network. Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial. JAMA Ophthalmol. 2013 Aug;131(8):1033-40. PMCID: PMC4162127
85. Domalpally A, Danis RP, Chew EY, Clemons TE, Reed S, Sangiovanni JP, Ferris FL 3rd, Age-Related Eye Disease Study 2 Research Group. Evaluation of optimized digital fundus reflex photographs for lens opacities in the age-related eye disease study 2: AREDS2 report 7. Invest Ophthalmol Vis Sci. 2013 Sep 05;54(9):5989-94. PMCID: PMC3771555
86. Age-Related Eye Disease Study 2 (AREDS2) Research Group, Chew EY, Clemons TE, Sangiovanni JP, Danis RP, Ferris FL 3rd, Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE, Hubbard GB, Klein ML, Chandra SR, Blodi BA, Domalpally A, Friberg T, Wong WT, Rosenfeld PJ, Agrón E, Toth CA, Bernstein PS, Sperduto RD. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. JAMA Ophthalmol. 2014 Feb;132(2):142-9. PMCID: PMC4636082
87. Flatter JA, Cooper RF, Dubow MJ, Pinhas A, Singh RS, Kapur R, Shah N, Walsh RD, Hong SH, Weinberg DV, Stepien KE, Wirostko WJ, Robison S, Dubra A, Rosen RB, Connor TB Jr, Carroll J. Outer retinal structure after closed-globe blunt ocular trauma. Retina. 2014 Oct;34(10):2133-46. PMCID: PMC4175068
88. Wilk MA, McAllister JT, Cooper RF, Dubis AM, Patitucci TN, Summerfelt P, Anderson JL, Stepien KE, Costakos DM, Connor TB Jr, Wirostko WJ, Chiang PW, Dubra A, Curcio CA, Brilliant MH, Summers CG, Carroll J. Relationship between foveal cone specialization and pit morphology in albinism. Invest Ophthalmol Vis Sci. 2014 May 20;55(7):4186-98. PMCID: PMC4098060
89. Boyer DS, Goldbaum M, Leys AM, Starita C, V.I.S.I.O.N. Study Group. Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study. Br J Ophthalmol. 2014 Nov;98(11):1543-6.
90. Land ME, Cooper RF, Young J, Berg E, Kitchner T, Xiang Q, Szabo A, Ivacic LC, Stepien KE, Page CD, Carroll J, Connor T Jr, Brilliant M. Cone structure in subjects with known genetic relative risk for AMD. Optom Vis Sci. 2014 Aug;91(8):939-49. PMCID: PMC4111779
91. Diabetic Retinopathy Clinical Research Network, Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015 Mar 26;372(13):1193-203. PMCID: PMC4422053
92. Bressler SB, Almukhtar T, Bhorade A, Bressler NM, Glassman AR, Huang SS, Jampol LM, Kim JE, Melia M, Diabetic Retinopathy Clinical Research Network Investigators. Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment. JAMA Ophthalmol. 2015 May;133(5):589-97. PMCID: PMC4496789
93. Aiello LP, Ayala AR, Antoszyk AN, Arnold-Bush B, Baker C, Bressler NM, Elman MJ, Glassman AR, Jampol LM, Melia M, Nielsen J, Wolpert HA, Diabetic Retinopathy Clinical Research Network. Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial. JAMA Ophthalmol. 2015 Aug;133(8):888-96. PMCID: PMC4924347
94. Aref AA, Scott IU, Oden NL, Ip MS, Blodi BA, VanVeldhuisen PC, SCORE Study Investigator Group. Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15. JAMA Ophthalmol. 2015 Sep;133(9):1022-9. PMCID: PMC6639714
95. Brilliant MH, Vaziri K, Connor TB Jr, Schwartz SG, Carroll JJ, McCarty CA, Schrodi SJ, Hebbring SJ, Kishor KS, Flynn HW Jr, Moshfeghi AA, Moshfeghi DM, Fini ME, McKay BS. Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration. Am J Med. 2016 Mar;129(3):292-8. PMCID: PMC4841631
96. Wells JA, Glassman AR, Jampol LM, Aiello LP, Antoszyk AN, Baker CW, Bressler NM, Browning DJ, Connor CG, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW, Diabetic Retinopathy Clinical Research Network. Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema. JAMA Ophthalmol. 2016 Feb;134(2):127-34. PMCID: PMC5567793
97. AREDS2 Research Group, Al-Holou SN, Tucker WR, Agrón E, Clemons TE, Sperduto RD, Ferris FL 3rd, Chew EY. The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8. Ophthalmology. 2016 Apr;123(4):916-7. PMCID: PMC4808327
98. Wells JA, Glassman AR, Ayala AR, Jampol LM, Bressler NM, Bressler SB, Brucker AJ, Ferris FL, Hampton GR, Jhaveri C, Melia M, Beck RW, Diabetic Retinopathy Clinical Research Network. Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial. Ophthalmology. 2016 Jun;123(6):1351-9. PMCID: PMC4877252
99. Razeen MM, Cooper RF, Langlo CS, Goldberg MR, Wilk MA, Han DP, Connor TB Jr, Fishman GA, Collison FT, Sulai YN, Dubra A, Carroll J, Stepien KE. Correlating Photoreceptor Mosaic Structure to Clinical Findings in Stargardt Disease. Transl Vis Sci Technol. 2016 Mar;5(2):6. PMCID: PMC4790429
100. Sun LW, Johnson RD, Langlo CS, Cooper RF, Razeen MM, Russillo MC, Dubra A, Connor TB Jr, Han DP, Pennesi ME, Kay CN, Weinberg DV, Stepien KE, Carroll J. Assessing Photoreceptor Structure in Retinitis Pigmentosa and Usher Syndrome. Invest Ophthalmol Vis Sci. 2016 May 01;57(6):2428-42. PMCID: PMC5089122
101. Mauck M, Mancuso K, Kuchenbecker J, Connor TB, Hauswirth W, Neitz j, Neitz M. Longitudinal evaluation of expression of virally delivered transgenes in gerbil cone photoreceptors Visual Neuroscience. 25: 273-282.
102. Vitale S, Clemons TE, Agrón E, Ferris FL 3rd, Domalpally A, Danis RP, Chew EY, Age-Related Eye Disease Study 2 (AREDS2) Research Group. Evaluating the Validity of the Age-Related Eye Disease Study Grading Scale for Age-Related Macular Degeneration: AREDS2 Report 10. JAMA Ophthalmol. 2016 Sep 01;134(9):1041-7. PMCID: PMC8371745
103. Patterson EJ, Wilk M, Langlo CS, Kasilian M, Ring M, Hufnagel RB, Dubis AM, Tee JJ, Kalitzeos A, Gardner JC, Ahmed ZM, Sisk RA, Larsen M, Sjoberg S, Connor TB, Dubra A, Neitz J, Hardcastle AJ, Neitz M, Michaelides M, Carroll J. Cone Photoreceptor Structure in Patients With X-Linked Cone Dysfunction and Red-Green Color Vision Deficiency. Invest Ophthalmol Vis Sci. 2016 Jul 01;57(8):3853-63. PMCID: PMC4968428
104. Jampol LM, Glassman AR, Bressler NM, Wells JA, Ayala AR, Diabetic Retinopathy Clinical Research Network. Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema: Additional Efficacy Post Hoc Analyses of a Randomized Clinical Trial. JAMA Ophthalmol. 2016 Dec 01;134(12). PMCID: PMC5567802
105. Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Figueroa M, Dugel PU, SCORE2 Investigator Group. SCORE2 Report 2: Study Design and Baseline Characteristics. Ophthalmology. 2017 Feb;124(2):245-256. PMCID: PMC5272814
106. Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Awh CC, Kunimoto DY, Marcus DM, Wroblewski JJ, King J, SCORE2 Investigator Group. Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial. JAMA. 2017 May 23;317(20):2072-2087. PMCID: PMC5710547
107. Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, King J, Antoszyk AN, Peters MA, Tolentino M, SCORE2 Investigator Group. Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4. JAMA Ophthalmol. 2017 Jun 01;135(6):639-649. PMCID: PMC5710260
108. Scott IU, Figueroa MJ, Oden NL, Ip MS, Blodi BA, VanVeldhuisen PC, SCORE2 Investigator Group. SCORE2 Report 5: Vision-Related Function in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion. Am J Ophthalmol. 2017 Dec;184:147-156. PMCID: PMC5798626
109. Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Altaweel M, Berinstein DM, SCORE2 Investigator Group. Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical Trial. JAMA Ophthalmol. 2018 Apr 01;136(4):337-345. PMCID: PMC5876862
110. Jampol LM, Glassman AR, Liu D, Aiello LP, Bressler NM, Duh EJ, Quaggin S, Wells JA, Wykoff CC, Diabetic Retinopathy Clinical Research Network. Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema. Ophthalmology. 2018 Jul;125(7):1054-1063. PMCID: PMC6568257
111. Desai S, Connor TB Jr, Kopplin LJ. Photophobia in an Immunocompromised Patient. JAMA Ophthalmol. 2018 Aug 01;136(8):946-947.
112. Lapierre-Landry M, Connor TB, Carroll J, Tao YK, Skala MC. Photothermal optical coherence tomography of indocyanine green in ex vivo eyes. Opt Lett. 2018 Jun 01;43(11):2470-2473. PMCID: PMC8148624
113. Warren CC, Young JB, Goldberg MR, Connor TB, Kassem IS, Costakos DM. Findings in Persistent Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2018 Jul 01;49(7):497-503. PMCID: PMC6196355
114. Gross JG, Glassman AR, Liu D, Sun JK, Antoszyk AN, Baker CW, Bressler NM, Elman MJ, Ferris FL 3rd, Gardner TW, Jampol LM, Martin DF, Melia M, Stockdale CR, Beck RW, Diabetic Retinopathy Clinical Research Network. Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial. JAMA Ophthalmol. 2018 Oct 01;136(10):1138-1148. PMCID: PMC6233839
115. Keenan TD, Agrón E, Domalpally A, Clemons TE, van Asten F, Wong WT, Danis RG, Sadda S, Rosenfeld PJ, Klein ML, Ratnapriya R, Swaroop A, Ferris FL 3rd, Chew EY, AREDS2 Research Group. Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16. Ophthalmology. 2018 Dec;125(12):1913-1928. PMCID: PMC6246813
116. Reid CA, Nettesheim ER, Connor TB, Lipinski DM. Development of an inducible anti-VEGF rAAV gene therapy strategy for the treatment of wet AMD. Sci Rep. 2018 Aug 06;8(1):11763. PMCID: PMC6079038
117. Yu JJ, Agrón E, Clemons TE, Domalpally A, van Asten F, Keenan TD, Cukras C, Chew EY, Age-Related Eye Disease Study 2 Research Group. Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17. Ophthalmology. 2019 Feb;126(2):261-273. PMCID: PMC6348044
118. Ip MS, Oden NL, Scott IU, VanVeldhuisen PC, Blodi BA, Ghuman T, Baker CW, SCORE2 Investigator Group. Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study. JAMA Ophthalmol. 2019 Mar 01;137(3):281-287. PMCID: PMC6439712
119. Koenig SB, Koenig LR, Connor TB, Simons KB. Successful management of epithelial ingrowth after sequential intracameral 5-fluorouracil and Descemet-stripping automated endothelial keratoplasty. J Cataract Refract Surg. 2019 May;45(5):690-693.
120. Young JB, Godara P, Williams V, Summerfelt P, Connor TB, Tarima S, Visotcky A, Cooper RF, Blindauer K, Carroll J. Assessing Retinal Structure in Patients with Parkinson's Disease. J Neurol Neurophysiol. 2019;10(1). PMCID: PMC6494090
121. Scott IU, VanVeldhuisen PC, Barton F, Oden NL, Ip MS, Blodi BA, Worrall M, Fish GE, Study of Comparative Treatments for Retinal Vein Occlusion 2 Investigator Group. Patient-Reported Visual Function Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: Preplanned Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 2019 Aug 01;137(8):932-938. PMCID: PMC6555474
122. Maguire MG, Liu D, Glassman AR, Jampol LM, Johnson CA, Baker CW, Bressler NM, Gardner TW, Pieramici D, Stockdale CR, Sun JK, DRCR Retina Network. Visual Field Changes Over 5 Years in Patients Treated With Panretinal Photocoagulation or Ranibizumab for Proliferative Diabetic Retinopathy. JAMA Ophthalmol. 2020 Mar 01;138(3):285-293. PMCID: PMC7042909
123. Chua MR, Giovinazzo JV, Kaplan RI, Connor T, Kellner C, Barash A, Rosen RB. PARACENTRAL ACUTE MIDDLE MACULOPATHY AS A PRESENTING SIGN OF CENTRAL RETINAL ARTERY OCCLUSION IN SICKLE CELL DISEASE TREATED WITH TISSUE PLASMINOGEN ACTIVATOR. Retin Cases Brief Rep. 2022 Sep 01;16(5):553-557.
124. Hendrick A, VanVeldhuisen PC, Scott IU, King J, Blodi BA, Ip MS, Khurana RN, Oden NL, SCORE2 Investigator Group. SCORE2 Report 13: Intraretinal Hemorrhage Changes in Eyes With Central or Hemiretinal Vein Occlusion Managed With Aflibercept, Bevacizumab or Observation. Secondary Analysis of the SCORE and SCORE2 Clinical Trials. Am J Ophthalmol. 2021 Feb;222:185-193. PMCID: PMC7895852
125. Litts KM, Woertz EN, Wynne N, Brooks BP, Chacon A, Connor TB, Costakos D, Dumitrescu A, Drack AV, Fishman GA, Hauswirth WW, Kay CN, Lam BL, Michaelides M, Pennesi ME, Stepien KE, Strul S, Summers CG, Carroll J. Examining whether aoslo-based foveal cone metrics in achromatopsia and albinism are representative of foveal cone structure Translational Vision Science and Technology. 2021;10(6).
126. Litts KM, Woertz EN, Wynne N, Brooks BP, Chacon A, Connor TB, Costakos D, Dumitrescu A, Drack AV, Fishman GA, Hauswirth WW, Kay CN, Lam BL, Michaelides M, Pennesi ME, Stepien KE, Strul S, Summers CG, Carroll J. Examining whether aoslo-based foveal cone metrics in achromatopsia and albinism are representative of foveal cone structure Translational Vision Science and Technology. 2021;10(6).
127. Patel DD, Dhalla AH, Viehland C, Connor TB, Lipinski DM. Development of a Preclinical Laser Speckle Contrast Imaging Instrument for Assessing Systemic and Retinal Vascular Function in Small Rodents. Transl Vis Sci Technol. 2021 Aug 02;10(9):19. PMCID: PMC8374978
128. Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA, SCORE2 Investigator Group. SCORE2 Report 17: Macular thickness fluctuations in anti-VEGF-treated patients with central or hemiretinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2022 May;260(5):1491-1500. PMCID: PMC10887424
129. Mahaling B, Low SWY, Beck M, Kumar D, Ahmed S, Connor TB, Ahmad B, Chaurasia SS. Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders International Journal of Molecular Sciences. March-1 2022;23(5).
130. Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, SCORE2 Investigator Group. Month 60 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion. Am J Ophthalmol. 2022 Aug;240:330-341. PMCID: PMC11064059
131. Mahaling B, Low SWY, Ch S, Addi UR, Ahmad B, Connor TB, Mohan RR, Biswas S, Chaurasia SS. Next-Generation Nanomedicine Approaches for the Management of Retinal Diseases. Pharmaceutics. 2023 Jul 22;15(7). PMCID: PMC10383092
132. Sepah YJ, Do DV, Mesquida M, Day BM, Blotner S, Afridi R, Halim MS, Hong K, Wakshull E, Fauser S, Stoilov I, Dong Nguyen Q, HARBOR, READ-3 Investigators. Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy. Eye (Lond). 2024 Jun;38(9):1755-1761. PMCID: PMC11156666
133. Writing Committee for the DRCR Retina Network, Ehlers JP, Josic K, Yordi S, Martin A, Srivastava SK, Sun JK. Assessment of Baseline Ultrawidefield Fluorescein Angiographic Quantitative Leakage Parameters with Ultrawidefield Fundus Features and Clinical Parameters in Diabetic Retinopathy in Protocol AA. Ophthalmol Retina. 2025 Mar;9(3):243-252. PMCID: PMC11868455
134. Kolli A, Wong J, Duret S, Stewart JM, Connor TB, Roorda A, Carroll J, Duncan JL. Outer retinal reflectivity and visual function loss after anatomically successful macula-off rhegmatogenous retinal detachment repair American Journal of Ophthalmology Case Reports. June 2025;38.
135. Parekh BJ, Stein JD, Abuzaitoun R, Andrews CA, Branham K, Milentijevic D, Narayanan D, Khan NW, Pershing S, Wang SY, Ahmad BU, Connor TB, Patnaik JL, Mathias M, Leys M, McMillan B, Amakiri N, Johnson TJ, Sun CQ, Duncan JL, Jayasundera KT, SOURCE consortium. Decline of Visual Function and Risk of Legal Blindness With Age in RPGR-Associated Retinal Degeneration: A Multicenter Study. Clin Exp Ophthalmol. 2026 Feb 27.
136. Silva PS, Liu D, Aiello LP, Grigorian R, Grover S, Jampol LM, Martin DF, Melia M, Weng CY, Sun JK, DRCR Retina Network. Diabetic Retinopathy Severity on Ultra-Widefield Fluorescein Angiography versus Color Photography and Association with Risk of Disease Worsening. Ophthalmol Sci. 2026 Jun;6(6):101182. PMCID: PMC13156741
 
Books, Chapters, and Reviews
1. Glaser BM, Kalebic T, Gabrisa S, Connor TB, Liotta LA. Degradation of basement membrane components by vascular endothelial cells: role in neovascularization. In Retinal Diseases. Eds. Ryan SJ, Dawson AK, Little HL. Grune and Stratton, New York, pp. 21-34, 1985.
2. Glaser BM, Connor TB Jr, Roberts AB, Sporn MB, Danielpour D, Dart LL, Michels RG, deBustros S, Enger C. Correlation of fibrosis and transforming growth factor beta type II levels in the eye. In Proliferative Vitreoretinopathy. Eds Heimann K, Wiedemann P. Kaden Verlag, Heidelberg, pp. 120-127, 1989.
3. Connor TB, Traboulsi EI. Retinopathies and nyctalopia. In Decision Making in Pediatric Ophthalmology. Eds. Cibis GW, Tongue AC, Stass-Isern ML. Mosby Year Book, St. Louis, pp. 216-219, 1993.
4. Connor TB. Ocular Examination in Essentials of Eyecare. Ed. Varma R. Lippincott-Raven, pp. 26-38, 1997.
5. MacCumber MW, Connor TBjr, Bressler NW. Traumatic Maculopathies in Management of Ocular Injuries and Emergencies. Ed. MacCumber MW. Lippincot-Raven, pp. 319-332, 1998.
6. Connor TB. Infectious Retinitis in Ophthalmic Surgery: Principles and Techniques. Ed. Albert DM. Blackwell Science, Malden MA, pp. 642-649, 1999.
 
Abstracts
1. 1. Connor TB, Glaser BM. Purification of a retina-derived stimulator of vascular endothelial cell migration. Invest Ophthalmol Vis Sci 22(Suppl):109, 1982. 2. Glaser BM, Connor TB, Michels RG. Effect of human intraocular fluid on vascular endothelial cell migration. Invest Ophthalmol Vis Sci 22(Suppl):109, 1982. 3. Glaser BM, Connor TB. Protamine inhibits plasminogen activators derived from vascular endothelial cells and tumor cells. J Cell Biol 95:115a, 1982. 4. Connor TB, Davis JL, Glaser BM. Protamine inhibits endothelial cell plasminogen activators. Invest Ophthalmol Vis Sci 24(Suppl):251, 1983. 5. Glaser BM, Connor TB, Davis JL, Kalebic T, Liotta L. Vascular endothelial cell degradation of basement membranes. Invest Ophthalmol Vis Sci 24(Suppl):111, 1983. 6. Graeber JE, Walenga RW, Connor TB, Stuart MJ, Glaser BM. A platelet metabolite inhibits endothelial cell migration. Invest Ophthalmol Vis Sci 24(Suppl):254, 1983. 7. Mandel RJ, Connor TB, Glaser BM. Techniques for isolating retinal capillary fragments. Invest Ophthalmol Vis Sci 24(Suppl):254, 1983. 8. Sternberg P, Connor TB, Vidaurri JS, Glaser BM. A new method for quantifying RPE cell migration. Invest Ophthalmol Vis Sci 24(Suppl):254 1983. 9. Davis JL, Connor TB, Glaser BM. Purification of tissue plasminogen activator from vascular endothelial cells. Invest Ophthalmol Vis Sci 25(Suppl):316, 1984.
2. 10. Connor TB, Glaser BM. RPE cells can simultaneously release inhibitors and stimulators of endothelial cell proliferation. Invest Ophthalmol Vis Sci 28(Suppl):203, 1987. 11. Lemor M, Hyer K, Davis J, Connor T, Glaser B. Sub-retinal fluid from experimental retinal detachments stimulates RPE cell and astrocyte proliferation. Invest Ophthalmol Vis Sci 28 suppl: 206, 1987. 12. Davis J, Connor T, Krause W, Hyer K, Glaser B. Ocular modulators of RPE protease inhibitors: role in control of neovascularization. Invest Ophthalmol Vis Sci 28(Suppl):204, 1987. 13. Connor T, Hayashi H, Krause W, Davis J, Glaser BM. Transforming growth factor-beta inhibits plasminogen activator activity of vascular endothelial cells. J Cell Biol 105:274a, 1987. 14. Connor TB, Roberts AB, Sporn MB, Davis J, Glaser BM. RPE cells synthesize and release transforming growth factor-beta, a modulator of endothelial cell growth and wound healing. Invest Ophthalmol Vis Sci 29(Suppl):307, 1988. 15. Smiddy WE, Connor TB, Green WR, Roberts AB, Sporn MB, Glaser BM. Transforming growth factor beta, a biologic retinal glue. Invest Ophthalmol Vis Sci 29(Suppl):221, 1988 16. MacCumber MW, Connor TB, Hayashi H, Krause WG, Glaser BM. Transforming growth factor-beta modulates vascular endothelial cell protease activity: role in blood vessel invasion. Invest Ophthalmol Vis Sci 29(Suppl):246, 1988. 17. Connor TB, Guyton DL. The adjustable globe: a novel technique for strabismus surgery. Invest Ophthalmol Vis Sci 32(Suppl):759, 1991. 18. Connor TB, Repka MX, D'Anna S, Guyton DL. Anterior segment ischemia from "adjustable globe" strabismus surgery? Ophthalmology 98(Suppl): 214, 1991.
3. 19. Connor TB, Javitt JC, Canner JK, Schachat AP. Survival following enucleation or plaque therapy for choroidal melanoma: a review of the medicare database. Invest Ophthalmol Vis Sci 33(Suppl):1254, 1992. 20. Pulido JS, Burton TC, Hartz AJ, Roberts GJ, Connor TB Jr, Howe CA. Differences in ocular disease among ethnic groups. Ophthalmology 100(Suppl 9A):123, 1993. 21. Law SK, Kalenak JW, Connor TBjr, Mieler WF, Pulido JS, Han DP. Retinal complications of glaucoma tube-shunt surgery. Ophthalmology 102(suppl 9A):172, 1995. 22. Law SK, Kalenak JW, Connor TBjr, Pulido JS, Han DP, Mieler WF. Retinal complications following glaucoma aqueous-shunt surgery. Invest Ophthalmol Vis Sci 37(suppl): S257, 1996. 23. Law SK, Kalenak JW, Trible JR, Connor TBjr, Pulido JS, Han DP, Mieler WF. Retinal complications following Ahmed valve implantation. Ophthalmology 103(suppl 9A):147, 1996. 24. Mittra RA, Huynh LT, Connor TBjr, Han DP, Mieler WF, Pulido JS. Visual outcome following pars plana lensectomy/vitrectomy for combined anterior and posterior hyperplastic primary vitreous. Ophthalmology 104(suppl 9A):154, 1997. 25. Wirostko W, Han DP, Pulido JS, Connor TBjr, Mieler WF. Suprachoroidal hemorrhage: outcome of surgical management according to hemorrhage severity. Ophthalmology 104(suppl 9A):185, 1997. 26. Law SK, Kalenak JW, Trible JR, Connor TBjr, Pulido JS, Han DP, Mieler WF. Postoperative hypotony and retinal complications following ahmed glaucoma valve implantation. Invest Ophthalmol Vis Sci 38(suppl): S12, 1997. 27. Han DP, Moshin N, Guise CE, Hartz AJ, Tarkanian C, Wolf MD, Sramek SJ, Mieler WF, Pulido JS, Connor TB. Comparison of pneumatic retinopexy versus scleral buckling in the management of primary rhegmatogenous retinal detachment. Invest Ophthalmol Vis Sci 38(suppl): S483, 1997.
4. 28. Mittra RA, Connor TB, Han DP, Mieler WF, Pulido JS. Management of dislocated posterior chamber intraocular lenses using pars plana vitrectomy combined with insertion of an anterior chamber lens. Invest Ophthalmol Vis Sci 38(suppl): S667, 1997. 29. Wirostko WJ, Han DP, Mieler WF, Pulido JS, Hartz AJ, Guidse CE. Suprachoroidal hemorrhage: a classification of severity and its association with visual and anatomic outcome. Invest Ophthalmol Vis Sci 38(suppl): S670, 1997. 30. McCabe CM, Mieler WF, Han DP, Pulido JS, Connor TB. Retinal detachment following macular hole surgery. Invest Ophthalmol Vis Sci 38(suppl): S737, 1997. 31. Dev S, Pulido JS, Tessler HH, Mittra RA, Han DP, Connor TB, Mieler WF. Progression of Diabetic Retinopathy after Endophthalmitis. Invest Ophthalmol Vis Sci 39(suppl): S674, 1998. 32. Mittra RA, Pollack JS, Dev S, Han DP, Mieler WF, Connor TB, Pulido JS. The Use of Topical Aqueous Suppressants in the Prevention of Postoperative Intraocular Pressure (IOP) Elevation Following Pars Plana Vitrectomy (PPV) with Long-Acting Gas Tamponade. Invest Ophthalmol Vis Sci 39(suppl): S376, 1998. 33. Connor TB, Koenig SB, Graul TA, Sheth BP. Management of Lens Dislocation with Pars Plana Lensectomy/Vitrectomy and Temporal Incision for IOL Placement. Invest Ophthalmol Vis Sci 39(suppl): S62, 1998. 34. Levin DS, Dev S, Wirostko WJ, Han DP, Mieler WF, Connor TBjr. Posterior subtenon corticosteroid injections in patients with a history of corticosteroid-induced IOP elevation. Invest Ophthalmol Vis Sci 40(Suppl): S384, 1999. 35. Carnahan MC, Wirostko WJ, Perkins SJ, Han DP, Kim JE, Connor TBjr. Safety of cataract extraction following central retinal vein occlusion. Invest Ophthalmol Vis Sci 41(Suppl): S645, 2000. 36. Perkins SJ, Kim JE, Wirostko WJ, Han, DP, Connor TBjr. Clinical characteristics of central series retinopathy in woman. Invest Ophthalmol Vis Sci 41 (Suppl): S: 358, 2000.
 
Database, Video, or Other Research/Clinical Contributions
1. Video Presentations Koenig SB, Han DP, Connor TB Jr. Combined penetrating keratoplasty, extracapsular cataract extraction, and pars plana vitrectomy using an Eckardt keratoprosthesis. Ophthalmology 100(Suppl 9A):152, 1993.